Agilux Laboratories is a Contract Research Organization (CRO) proudly serving pharmaceutical and biotech clients in North America and around the world. Agilux was founded by veterans of the pharmaceutical and CRO industry to provide intelligent solutions to the challenges of drug discovery and development. Our exceptional service and client responsiveness have allowed us to steadily expand the scope of our capabilities and capacities. We are here to provide you with Better Data Faster and are pleased to offer our expertise in the following service areas:
Agilux fully understands and is committed to providing the services demanded by the speed requirements of discovery. We have built our processes and operations around the need for speed, enabling us with no prior notice to deliver quality data supporting studies of many designs and complexities in three to five days. Our Research Grade Assays (RGA’s) incorporate our unique Discovery 2.0 diagnostic features. Learn More:
We have built our processes to respond to your needs to initiate programs with little-to-no required advanced notice. Activity-based, global IACUC protocol approvals together with one page protocols enable us to initiate studies anddeliver samples within days. If you combine this service with our discovery bioanalysis and WinNonLin PK analysis,we deliver your PK parameters in less than five days from dosing. Agilux offers In Vivo PK services in rodent and non-rodent species from our AAALAC accredited facilities.
.You can choose to use our In Vivo services as a standalone or part of a fully integrated service. Learn More:
Expert study designs and data interpretation from the In Vitro Services group at Agilux, allow you to characterize your drug candidate's ADME properties and its potential for drug-drug interactions with our In Vitro ADME assays. Each of our In Vitro assays can be offered as an early screening single determination or a more definitive study to determine in-depth PK/ ADME characteristics. Our team of experienced Study Directors can also assist in designing the best strategy and protocols customized to suit any drug discovery program. Learn More:
Agilux has the experience and capability to measure biomarkers by the most appropriate means, either ligand binding (ELISA) or LC-MS/MS. Agilux can custom develop a fit-for-purpose biomarker assay to meet your specific needs or run commercially available assays. Agilux takes these challenging assays and makes the running of samples routine.
At Agilux Laboratories, we have decades of experience in the unique complexities of small molecule biomarker assay development and operation. With expertise in managing matrix issues for endogenous compounds and harnessing the best in chromatographic separations for mass spectrometric analysis, Agilux can develop efficient, effective LC-MS/MS biomarker assays ranging from small organic acids to peptides. Learn More:
Agilux’s GLP bioanalytical services are all about delivering on our commitment to meet program schedules and provide high quality data. Agilux combines its significant experience in quantitative LC-MS/MS bioanalysis, innovative science, and efficient, validated processes to deliver quality data on time. Learn More:
The Project Team needed data from a guinea pig study to proceed forward quickly due to shortened timelines. Your employee was able to turnaround data in less than 24 hours and did so while maintaining excellent communications.
There have been several instances where studies have shown up un-announced and your employee was able to analyze and report data quickly despite not having information prior to the study arriving. Additionally, he recently accepted a study containing several hundred samples and three different matrices and was able to provide data in less than five business days.
High quality data is always delivered. Any outliers in the assays are identified and any issues are presented clearly and concisely, including his opinion regarding the cause and impact.